SCHEMBL431903

SCHEMBL431903

NCC(CCO)(CCO)S(=O)(=O)O

nearest known ligand 0.31

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.31
SLC6A6 P31641 1/20 0.31
CYP2C19 P33261 1/20 0.31
BLM P54132 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18264122 0.98
SCHEMBL1535002 0.79
Methylamine SCHEMBL8745534 0.78
SCHEMBL21495971 0.78 FDPS (0.38)
SCHEMBL10631993 0.78 APP (0.42) LMNASLC6A6CYP2C19BLM
SCHEMBL18264124 0.76 GMNN (0.30) LMNA
SCHEMBL28246887 0.73 THRB (0.35) LMNABLM
SCHEMBL21495968 0.72 LMNA (0.32) LMNASLC6A6CYP2C19BLM
SCHEMBL8662505 0.71
SCHEMBL27674692 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 190 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4731759-A2 ENZYMES Global Life Sciences Solutions Operations UK Limited (GB) 2026-04-29 EP claimed
WO-2024261083-A2 ENZYMES GLOBAL LIFE SCIENCES SOLUTIONS OPERATIONS UK LIMITED (GB) 2024-12-26 WO claimed
EP-4294371-A1 AQUEOUS COMPOSITION OF AN ENGINEERED PROTEIN CONSTRUCT COMPRISING AN FC DOMAIN Arecor Limited (GB) 2023-12-27 EP claimed
CN-112313727-B Method and package for preparing buffer solution and kit for clinical test 瑞乐文特生物有限公司 2023-12-22 CN claimed
WO-2023237485-A1 STABLE LYOPHILISATES COMPRISING 5,10-METHYLENE-(6R)-TETRAHYDROFOLIC ACID MERCK PATENT GMBH (DE) 2023-12-14 WO claimed
EP-4244236-A1 PATHOGEN INACTIVATING AND NUCLEIC ACID STABILIZATION MEDIA FOR MICROORGANISM COLLECTION AND TRANSPORT Biocept, Inc. (US) 2023-09-20 EP claimed
EP-4010365-A1 NOVEL COMPOSITION COMPRISING ANTIBODIES Arecor Limited (GB) 2022-06-15 EP claimed
WO-2022103978-A1 PATHOGEN INACTIVATING AND NUCLEIC ACID STABILIZATION MEDIA FOR MICROORGANISM COLLECTION AND TRANSPORT BIOCEPT, INC. (US) 2022-05-19 WO claimed
EP-3897573-A1 NOVEL COMPOSITION Arecor Limited (GB) 2021-10-27 EP claimed
EP-3897572-A1 NOVEL COMPOSITION Arecor Limited (GB) 2021-10-27 EP claimed
WO-2009058997-A2 NON-INVASIVE ISOLATION OF FETAL NUCLEIC ACID BIOCEPT INC. (US) 2009-05-07 WO claimed
WO-2009049318-A2 FREEZE-DRIED PLASMA FORMATS FOR THE TRAUMA CARE FIELD BAKALTCHEVA IRINA B (US) 2009-04-16 WO claimed
EP-1853696-A2 ELECTRO-BLOTTING DEVICES, SYSTEMS, AND KITS, AND METHODS FOR THEIR USE INVITROGEN CORPORATION (US) 2007-11-14 EP claimed
WO-2006091525-A2 ELECTRO-BLOTTING DEVICES, SYSTEMS, AND KITS, AND METHODS FOR THEIR USE INVITROGEN CORPORATION (US) 2006-08-31 WO claimed
EP-1448607-A1 COMPOSITION AND METHOD TO HOMOGENEOUSLY MODIFY OR CROSS-LINK CHITOSAN UNDER NEUTRAL CONDITIONS Biosyntech Canada Inc. (CA) 2004-08-25 EP claimed
WO-2003042250-A1 COMPOSITION AND METHOD TO HOMOGENEOUSLY MODIFY OR CROSS-LINK CHITOSAN UNDER NEUTRAL CONDITIONS BIOSYNTECH CANADA INC. (CA) 2003-05-22 WO claimed
WO-2003010238-A1 PAPER COATING TEST METHOD AND COMPOSITION LEXMARK INTERNATIONAL, INC. (US) 2003-02-06 WO claimed
EP-1229940-A1 TEMPERATURE-CONTROLLED AND PH-DEPENDANT SELF-GELLING BIOPOLYMERIC AQUEOUS SOLUTION BIO SYNTECH CANADA INC. (CA) 2002-08-14 EP claimed
WO-2001036000-A1 TEMPERATURE-CONTROLLED AND PH-DEPENDANT SELF-GELLING BIOPOLYMERIC AQUEOUS SOLUTION BIO SYNTECH CANADA, INC. (CA) 2001-05-25 WO claimed
US-5142001-A Neutralization of a polyurethane containing hydrophilic acidic group with piperidine compound KYOWA HAKKO KOGYO CO., LTD. (JP) 1992-08-25 US claimed